Hypogonadismus obézních muž&#367

Area of Science:

• Endocrinology
• Metabolic Disorders
• Men's Health

Background:

• Male hypogonadism is associated with obesity through poorly understood mechanisms that promote fat deposition.
• Obesity can decrease androgen production, complicating the diagnosis and management of hypogonadism.
• Diagnosing hypogonadism relies on low testosterone levels and non-specific symptoms.

Purpose of the Study:

• To highlight the importance of accurate diagnosis and treatment of male hypogonadism in obese men.
• To discuss the impact of obesity on testosterone levels and the role of sex hormone-binding globulin (SHBG).
• To review effective treatment strategies for hypogonadism in the context of obesity.

Main Methods:

• Reviewing the relationship between obesity and androgen production.
• Evaluating diagnostic criteria for hypogonadism in obese individuals, including total and free testosterone measurements.
• Assessing treatment options such as testosterone substitution, body mass reduction, and bariatric surgery.

Main Results:

• Obesity significantly reduces SHBG levels, necessitating assessment of free testosterone or free androgen index.
• Hypogonadism in obese men requires a dual approach combining testosterone therapy and weight management.
• Bariatric surgery is identified as the most effective treatment for resolving hypogonadism in obese patients.

Conclusions:

• Accurate diagnosis of male hypogonadism in obese men is essential.
• Treatment should address both testosterone deficiency and excess body weight.
• Bariatric surgery offers a highly effective solution for obesity-induced hypogonadism.